Gefitinib Reverses PD-L1-Mediated Immunosuppression Induced by Long-term Glutamine Blockade in Bladder Cancer.
Ma G, Jia H, Li Z, Zhang X, Wang L, Zhang Z, Xiao Y, Liang Z, Li D, Chen Y, Tian X, Wang Y, Liang Y, Niu H.
Ma G, et al. Among authors: wang l, wang y.
Cancer Immunol Res. 2025 Jan 9;13(1):66-83. doi: 10.1158/2326-6066.CIR-24-0039.
Cancer Immunol Res. 2025.
PMID: 39470699